SEC Form 4 · accession 0001209191-19-010244
SUTRO BIOPHARMA, INC. · STRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel H Petree
Director
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | M | 3,030 | $5.09 | A | 3,030 | D | |
| Common StockF1 | holding | — | — | — | 192 | I | Daniel H. Petree and Susan Toeniskoetter Trust dated July 25, 1997 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F2 | $5.09 | Feb 12, 2019 | M | 3,030 | D | — | Mar 24, 2019 | Common Stock | 3,030 | 0 | D |
Explanation of responses
- F1These securities are held of record by the reporting person and his spouse as trustees of the Daniel H. Petree and Susan M. Toeniskoetter Trust dated July 25, 1997.
- F2The option is fully vested.